Liver Diseases: all 2,094 studies
Page 8 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant TumorsCompletedNCT06526754Not applicable
- MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian PatientsCompletedNCT06492369
- A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver DiseaseCompletedNCT06487325
- N-Acetyl Cysteine Effect on Liver Function After Mitral Valve ReplacementCompletedNCT06486805Phase 4
- Kosmos Anatomical Object Labeling and View Identification Pivotal StudyCompletedNCT06468787Not applicable
- Metabolic Dysfunction Associated Fatty Liver Disease in Long-Term Cholecystectomy PatientsCompletedNCT06443723Not applicable
- A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver DiseaseCompletedNCT06442137Phase 2
- Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic ImpairmentCompletedNCT06425198Phase 1
- A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASHCompletedNCT06410924Phase 2
- FC Change From Day 1 to Day 3 Associated With SALDCompletedNCT06403553
- EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular DiseasesCompletedNCT06392828
- Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLDCompletedNCT06389851Not applicable
- Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of BalcinrenoneCompletedNCT06388616Phase 1
- Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal ObesityCompletedNCT06377631Not applicable
- Split or Whole Liver Transplantation? A Multicenter Retrospective Cohort Study of Patients With Benign and Malignant Liver DiseaseCompletedNCT06359496
- The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT06357052
- A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic ImpairmentCompletedNCT06352528Phase 1
- Digital Therapeutic Lifestyle Intervention Program for Patients With MASLDWithdrawnNCT06352177Not applicable
- Digital Pathology and AI for Liver Outcomes in MASLDCompletedNCT06344364
- A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver FunctionCompletedNCT06340347Phase 1
- Manual Therapy in Metabolic Liver DiseaseCompletedNCT06338618Not applicable
- The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06338449Not applicable
- Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient MeasurementCompletedNCT06336850Not applicable
- A Research Study on Etavopivat in Participants With and Without Liver DiseaseCompletedNCT06336018Phase 1
- Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver TransplantationCompletedNCT06320730
- Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)CompletedNCT06319222Not applicable
- Genomic Medicine Risk Assessment Care for Everyone - Implementation PhaseCompletedNCT06278883Not applicable
- Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver DiseaseCompletedNCT06272630Phase 4
- A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver ProblemsTerminatedNCT06272058Phase 1
- Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis.CompletedNCT06267794Phase 2
- A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06256926Phase 2
- An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC DeficiencyActive, not recruitingNCT06255782Phase 3
- Effect of a Food Supplementation With a Combined Food Supplement on Lipid Pattern, Indexes of Non-alcoholic Fatty Liver Disease and Systemic InflammationCompletedNCT06247137Not applicable
- Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic FactorsCompletedNCT06244550Not applicable
- Aerobic Capacity Muscle Strength and Health Related Quality of Life in Children With Chronic Liver DiseaseCompletedNCT06240832Not applicable
- Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?CompletedNCT06229184Not applicable
- Contingency Management to Incentivise Treatment Adherence in Alcohol-related Liver DiseaseActive, not recruitingNCT06183710Not applicable
- MELD ESAS Evolution: Assessment of the Symptomatic Burden of Patients With Advanced Chronic Liver DiseaseCompletedNCT06181474
- Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Hepatic ImpairmentCompletedNCT06161259Phase 1
- A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD2389 in Healthy ParticipantsCompletedNCT06138795Phase 1
- A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And HyperoxaluriaWithdrawnNCT06138327Phase 1
- Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT06127225Phase 2
- A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic FunctionCompletedNCT06126575Phase 1
- Behavioral Lifestyle Intervention for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in AdultsCompletedNCT06121999Not applicable
- The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin ACompletedNCT06101433Not applicable
- Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting PrognosisActive, not recruitingNCT06099626
- Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver DiseaseCompletedNCT06097039
- A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 CirrhosisActive, not recruitingNCT06096779Phase 2
- A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of RelacorilantCompletedNCT06094725Phase 1
- DZD9008 PK Study in Hepatic Impairment SubjectsCompletedNCT06084104Phase 1
- The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning MethodsActive, not recruitingNCT06061640
- PK and Safety in Participants Taking Obicetrapib With Moderate Hepatic Impairment Relative to Normal Hepatic FunctionCompletedNCT06048302Phase 1
- Prediction of Early Recovery of Liver Function After LDLT in Children: An Ambispective Cohort StudyCompletedNCT06045949
- The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) SubjectsCompletedNCT06044467Phase 1
- Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06031532
- Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver DiseaseCompletedNCT06026293
- Impact of FMT on the Phenome in Patients With NAFLD and FibrosisCompletedNCT06024681Not applicable
- Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement StudyActive, not recruitingNCT06011356
- A Study to Evaluate the Pharmacokinetics of Avacopan (CCX168) in Participants With Mild or Moderate Hepatic ImpairmentCompletedNCT06004934Phase 1
- Surgical Treatment of Hydatid Liver DiseaseCompletedNCT05989516
- Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic SteatohepatitisActive, not recruitingNCT05979779Phase 2
- A Study of TAK-279 in Adults With or Without Liver DamageCompletedNCT05976321Phase 1
- Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)Active, not recruitingNCT05953337Not applicable
- Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).Active, not recruitingNCT05946330Not applicable
- Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)CompletedNCT05946148
- Early Liver Disease Breath DetectionCompletedNCT05935488
- A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of EmraclidineCompletedNCT05935033Phase 1
- Comparing Effects of Beetroot Juice and Mediterranean Diet on Liver Enzymes and Sonography in Patients With NAFLDCompletedNCT05909631Phase 1
- GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder SurgeryCompletedNCT05900037Not applicable
- Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLDCompletedNCT05897606Phase 1
- A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLDCompletedNCT05885373Not applicable
- Effects of Time-restricted Hypocaloric Diet in Patients with NAFLDCompletedNCT05866744Not applicable
- Pharmacokinetics of ZSP1273 in Participants With Hepatic ImpairmentCompletedNCT05856513Phase 1
- Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease PatientsStatus unknownNCT05849558Phase 4
- Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.Status unknownNCT05849220Not applicable
- Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary SyndromeCompletedNCT05843955
- A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic FunctionCompletedNCT05835180Phase 1
- SpyGlass Surgical StudyCompletedNCT05822635
- Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure RegistryWithdrawnNCT05817994
- GP681 in Volunteers With Hepatic Impairment Compared With Healthy VolunteersCompletedNCT05814926Phase 1
- Semaglutide in Nonalcoholic Fatty Liver DiseaseCompletedNCT05813249Phase 4
- UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver DiseaseStatus unknownNCT05812612
- Non-Alcoholic Fatty Liver Disease and Anthropometric MeasurementsCompletedNCT05810506
- Comparison Between Thromboelastography and Conventional Coagulation Tests in Pediatrics With Chronic Liver DiseaseStatus unknownNCT05809141
- A Clinical Trial to Evaluate the Efficacy and Safety of MXP22 on Liver HealthCompletedNCT05808049Not applicable
- Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal ObesityCompletedNCT05807204Not applicable
- Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease PatientsStatus unknownNCT05804409
- Quantitative Detection Efficiency of UDFF for Nonalcoholic Fatty Liver DiseaseStatus unknownNCT05802199
- Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD）CompletedNCT05795517Phase 2
- S100A8/A9 and Innate Immunity in Liver DiseaseStatus unknownNCT05793983
- Gut Mycobiome Profile in Alcoholic Liver Disease.Status unknownNCT05793190
- Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female SubjectsCompletedNCT05790304Phase 1
- Operator and Patient Acceptance of Radiofrequency Cautery of the Biopsy Track During Percutaneous Liver, Kidney or Spleen Biopsy Procedures.WithdrawnNCT05790109Not applicable
- Effectiveness of Oral Lactulose Versus Lactulose Enema in Hepatic EncephalopathyStatus unknownNCT05788627Phase 4
- Comparison of Hepatus and FibroScan for Evaluation of Fibrosis and SteatosisStatus unknownNCT05786963
- Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot StudyActive, not recruitingNCT05782972Phase 4
- Effect of L-citrulline and HIIT on Arterial Stiffness, Body Composition, and Lipid Profile in Adolescents with Steatosis Associated with Metabolic Dysfunction (MASLD)CompletedNCT05778266Not applicable
- Contrast Enhanced Ultrasound (CEUS) in Atypical Liver Nodules in Patients With Chronic Liver DiseaseCompletedNCT05772403
- Effect of Exercise Based Regimen on Frailty in Children With Liver DiseaseCompletedNCT05770284Not applicable
- Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT05768334Phase 3